2018
DOI: 10.1111/dth.12750
|View full text |Cite
|
Sign up to set email alerts
|

Topical diltiazem for ulceration of striae distensae associated with bevacizumab therapy

Abstract: patient continues in treatment with bevacizumab progression-free and keeps without ulcers.We describe the first case of ulceration of the striae distensae associated with bevacizumab resolved without disrupting the drug.The results obtained with topical diltiazem are promising to handle new cases.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 8 publications
0
2
0
Order By: Relevance
“…In lesional skin, VEGF immunohistology revealed the absence of endothelial immunoreactivity when compared to normal skin. The patient was treated with diltiazem cream 2% twice daily for three weeks 2 . However, ulcerations were progressive (Fig.…”
Section: Figurementioning
confidence: 99%
“…In lesional skin, VEGF immunohistology revealed the absence of endothelial immunoreactivity when compared to normal skin. The patient was treated with diltiazem cream 2% twice daily for three weeks 2 . However, ulcerations were progressive (Fig.…”
Section: Figurementioning
confidence: 99%
“…The management of most patients was performed with daily dressings and discontinuation of the associated medications. One report described improvement with topical diltiazem 5 …”
Section: Figurementioning
confidence: 99%